← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	GRML 101 Greenland Mines Ltd GRML $84.4M	–	–	–	–
102	102 Fractyl Health GUTS $22.2M	–	–	–	–
103	103 Immix Biopharma IMMX $676M	–	–	–	–
104	104 IN8bio INAB $10.9M	–	–	–	–
105	105 MiNK Therapeutics INKT $49.1M	–	–	–	–
106	106 Century Therapeutics IPSC $259M	–	–	–	–
107	KRBP 107 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
108	108 Kyverna Therapeutics KYTX $356M	–	–	–	–
109	LGVN 109 Longeveron LGVN $4.56M	–	–	–	–
110	110 Lexeo Therapeutics LXEO $227M	–	–	–	–
111	111 Lyell Immunopharma LYEL $201M	–	–	–	–
112	112 Metagenomi Therapeutics MGX $30.1M	–	–	–	–
113	113 NewcelX Ltd NCEL $14.8M	–	–	–	–
114	114 DELISTED NKGen Biotech, Inc. Common Stock NKGN	–	–	–	–
115	OBX 115 Obsidian Therapeutics OBX $732M	–	–	–	–
116	116 PharmaCyte Biotech PMCB $3.8M	–	–	–	–
117	117 Prime Medicine PRME $637M	–	–	–	–
118	118 ProKidney PROK $276M	–	–	–	–
119	119 Sana Biotechnology SANA $689M	–	–	–	–
120	SCPS 120 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
121	SCTX 121 Scribe Therapeutics Inc SCTX $377M	–	–	–	–
122	SGTX 122 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
123	SLBT 123 SL Science Holding Ltd SLBT $847M	–	–	–	–
124	124 Senti Biosciences Holdings SNTI $6.7M	–	–	–	–
125	SQZ 125 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–